Russia Trauma Devices Market Overview, 2031

Key Insights

• Russia's trauma fixation market is experiencing moderate growth, driven by rising incidences of road accidents, sports injuries, and an aging population susceptible to osteoporotic fractures. The market encompasses internal fixation devices and external fixation systems.
• Russia's trauma care infrastructure is extensive, featuring a network of specialized trauma centers. The Federal Centers for Traumatology, Orthopedics and Endoprosthetics in cities like Cheboksary and other regional trauma centers form the backbone of trauma care delivery across the country. In 2024, a regional trauma center performed over 16,500 surgical interventions, with 6,298 operations utilizing high medical technologies an increase of 1,500 cases compared to the previous year.
• The Russian medical device regulatory landscape underwent significant transformation in 2025. Roszdravnadzor registered 3,400 medical devices in 2025, with approximately 40% developed and manufactured in Russia. The new registration rules effective March 1, 2025, streamlined the process, reducing registration time for domestic devices from 50 days to just 10 days.

Market Outlook

• According to the research report, "Russia Trauma Devices Market Outlook, 2031," published by Bonafide Research, the Russia Trauma Devices Market is anticipated to grow at more than 4.54% CAGR from 2026 to 2031.
• The Russia Trauma Fixation Market is experiencing moderate growth, driven by rising incidences of road accidents, sports injuries, and an aging population susceptible to osteoporotic fractures. The market comprises internal fixation devices (such as plates, screws, nails, and intramedullary rods) and external fixation systems. Public hospitals dominate procurement, but private sector investments are increasing, particularly in urban centers.
• Western sanctions pose significant challenges for international manufacturers, leading to greater reliance on domestic companies and import substitution policies. Key international players include Medtronic, DePuy Synthes, and Smith & Nephew, alongside Russian firms like NPO ELAMED.
• Technological advancements, including minimally invasive procedures and bioresorbable implants, are gradually penetrating the market, though cost sensitivity remains high. Government efforts to modernize healthcare infrastructure and improve trauma care accessibility are expected to further boost demand, despite ongoing economic and regulatory uncertainties impacting the overall growth trajectory.

Policies

• Roszdravnadzor (Federal Service for Surveillance in Healthcare) is the primary regulatory authority responsible for medical device registration and oversight in Russia. The agency registered 3,400 medical devices in 2025, with approximately 40% developed and manufactured domestically.
• New Registration Rules (Government Resolution No. 1684) (March 2025) New rules for state registration of medical devices were introduced, significantly modernizing the market entry process. Key features include a 10-day registration process for domestic medical devices compared with 50 days previously and a "one-stop shop" principle providing full support from documentation development to dossier verification.
• National Standards (September 2025) Rosstandart approved GOST R ISO 18192-3-2025, establishing standards for surgical implants and wear testing of intervertebral disc prostheses.
• Clinical Trial Authorization Roszdravnadzor issued Order No. 4484 on July 22, 2025, establishing the procedure for maintaining the register of permits for conducting clinical trials of medical devices.
• Eurasian Economic Union (EAEU) Framework (2025) Russia continues to operate within the EAEU medical device regulatory framework, with national registration rules remaining effective until January 1, 2028.
• Industry Advocacy (August 2025) At the Vredenovskiye Chteniya scientific-practical conference in St. Petersburg, traumatologists and orthopedists proposed introducing unannounced inspections for implant manufacturers to ensure product quality and safety.

Industry News

• Rosatom Develops Domestic Surgical Instruments for Traumatology (June 2025) Rosatom metallurgists presented a full line-up of domestic surgical instruments for traumatology and orthopedics for the first time at the Eurasian Orthopedic Forum in Moscow. The key advantages include high manufacturing accuracy ensuring perfect coupling with implants and ergonomic design. A Rosatom subsidiary plans to launch large-scale production of implantable products for osteosynthesis by the end of the year.
• Russian Scientists Create Full-Cycle Biodegradable Implant Production (November 2025) Researchers at Tomsk Polytechnic University and the Ilizarov Center in Kurgan developed a complete cycle for manufacturing domestic bioresorbable bone implants, from 3D-printing material creation to implant fabrication and surface modification. These implants are already being applied at the Ilizarov Center.
• First Russian Flexible Sternal Implant Created (2025) Scientists from the ROSNANO Group developed Russia's first flexible sternal implant, offering improved flexibility and suitability for patients with severe chest trauma, oncological diseases of chest bones, or congenital developmental anomalies.
• New Medical Device Registration Rules Take Effect (March 2025) Government Resolution No. 1684 introduced new state registration rules for medical devices, featuring 10-day registration for domestic devices compared with 50 days previously, full "one-stop shop" support, and exclusive electronic document workflow through Gosuslugi. Roszdravnadzor described 2025 as a stage of forming a modern, digital, and effective medical device registration system.

Segment Analysis

Russia Trauma Devices Market By Product Type
• Internal fixation devices are used in approximately 450,000-600,000 orthopedic trauma procedures annually in Russia, including plates, screws, intramedullary nails, and locking fixation systems. Large trauma hospitals typically maintain 30-60 fixation implant systems to support emergency fracture treatment across different regions. A standard fixation procedure uses approximately 5-12 implant components, while revision procedures related to infection, implant loosening, or delayed union occur in approximately 20,000-35,000 cases annually.
• External fixation devices support approximately 50,000-80,000 trauma procedures annually in Russia, particularly for open fractures, battlefield-type injuries, severe limb trauma, and temporary stabilization. Major trauma centers generally stock 20-40 external fixation frame systems for emergency care. Each procedure typically requires 4-10 fixation pins or wires, with staged treatment approaches frequently used for complex fractures requiring multiple surgical interventions.
• Orthobiologics and synthetic bone grafts are utilized in approximately 70,000-100,000 trauma and reconstructive procedures annually in Russia. These products are primarily used for fracture non-unions, bone defects, and revision surgeries, with average graft requirements ranging from 5-25 cc per procedure. Specialized orthopedic institutions perform approximately 500-1,200 graft-assisted trauma procedures annually due to increasing adoption in complex fracture healing.



Russia Trauma Devices Market By Surgical Site / Anatomical Location
• Lower extremity trauma devices represent the largest application area, supporting approximately 350,000–500,000 procedures annually in Russia. Femur, tibia, ankle, and hip fractures contribute to more than 600,000 trauma related emergency evaluations annually. Complex lower limb fixation cases typically require 6–12 days of hospitalization, with rehabilitation periods extending from 3–12 months depending on injury severity.
• Pelvic trauma devices are utilized in approximately 30,000–50,000 surgical interventions annually in Russia. Pelvic and acetabular fractures result in approximately 80,000–120,000 trauma admissions annually, often associated with high energy accidents and industrial injuries. Operative pelvic fixation procedures commonly require 12–20 days of hospitalization, followed by prolonged rehabilitation and mobility recovery programs.
• Cranio-maxillofacial trauma devices support approximately 60,000–90,000 facial trauma procedures annually in Russia. Mandibular, orbital, and mid-face fractures represent major indications requiring specialized fixation systems. Titanium plate and screw systems are used in more than 40,000 facial fracture procedures annually, with additional reconstructive procedures performed for complex injuries.

Russia Trauma Devices Market By End User
• Hospitals are the primary users of trauma devices in Russia, supported by approximately 3,000-4,000 hospitals and trauma care facilities. These institutions perform more than 600,000 orthopedic trauma procedures annually and manage the majority of emergency fracture admissions. Major trauma hospitals typically handle 3,000-8,000 trauma surgeries annually and maintain extensive inventories of fixation devices and surgical instruments.
• Ambulatory Surgical Centers perform approximately 40,000-70,000 orthopedic trauma-related procedures annually in Russia, mainly involving minor fracture fixation, implant removal, and outpatient interventions. Individual centers typically complete 1,000-3,000 orthopedic procedures per year. ASCs are increasingly used for low-complexity trauma cases requiring shorter recovery periods and reduced hospital stays.
• Orthopedic clinics manage approximately 1.5-2.5 million trauma-related consultations annually across Russia, including fracture diagnosis, post-operative monitoring, and rehabilitation planning. Individual orthopedic specialists commonly evaluate 40-70 trauma patients per week. Clinics support long-term recovery through follow-up imaging, physiotherapy coordination, and implant surveillance.

Russia Trauma Devices Market By Material Type
• Stainless steel implants are used in approximately 180,000-250,000 trauma fixation procedures annually in Russia, primarily for standard plates, screws, and routine fracture applications. Many regional hospitals continue to stock stainless steel systems due to their durability and cost efficiency. Implant retention commonly exceeds 5-10 years, with replacement procedures mainly related to infection, discomfort, or mechanical complications.
• Titanium and titanium alloy implants are utilized in approximately 400,000-550,000 trauma procedures annually in Russia, particularly for complex orthopedic fixation. These materials are widely used in long-bone fractures, pelvic reconstruction, and cranio-maxillofacial procedures. Implant retention commonly exceeds 10 years, reducing the requirement for secondary implant removal surgeries.
• Bioabsorbable materials are used in approximately 15,000-30,000 trauma procedures annually in Russia, primarily in pediatric trauma, sports-related injuries, and selected reconstructive applications. These implants gradually degrade over 12-36 months, reducing the need for additional removal procedures. Their use remains concentrated in specialized orthopedic centers and advanced surgical institutions.

Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031

Aspects covered in this report
• Trauma Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Internal Fixation Devices
• External Fixation Devices
• Orthobiologics & Synthetic Bone Grafts
• Trauma Surgical Instruments & Accessories

By Surgical Site / Anatomical Location
• Upper Extremity Trauma Devices
• Lower Extremity Trauma Devices
• Pelvic Trauma Devices
• Cranio-Maxillofacial Trauma Devices

By End User
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Orthopedic Clinics

By Material Type
• Stainless Steel
• Titanium & Titanium Alloys
• Bioabsorbable Materials
• Other Materials